New study: a curcumin-carfilzomib combination is deadly to U266 myeloma cells

Well, well, well…

A few minutes ago a recently-published Italian study caught my eye. A group of researchers from the University of Messina (Sicily) has discovered that the combined effects of curcumin and carfilzomib (CFZ) are absolutely deadly to multiple myeloma U266 cells.  😎  

Here’s the link to the abstract: goo.gl/EBTwcc 

As we can read, the researchers conclude the following: “These findings evidence that curcumin can ameliorate CFZ efficacy, and lead us to hypothesize that this effect might be useful to optimize CFZ therapy in MM patients.

Indeed!

At any rate, I thought this study might be of huge interest to anyone who is taking carfilzomib right now…and so I wrote this quick post! But now I have to get back to my kittens (the vet is coming to visit them day after tomorrow…I so hope she will give us some GOOD NEWS…!!!).

Leave a Reply

Your email address will not be published. Required fields are marked *